ETF Portfolio Partners’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

ETF Portfolio Partners’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,232	Closed	-$10.6K	–	62
2024 Q1	$10.6K	Buy	+1,232	New	+$5.88K	﹤0.01%	60

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

ETF Portfolio Partners's TCON Position: Q2 2024 in Review

ETF Portfolio Partners sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 1,232 shares — an estimated $10.6K sold.

ETF Portfolio Partners first reported a position in TCON in Q1 2024 and held it in 1 quarter. The position peaked at $10.6K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

ETF Portfolio Partners reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
ETF Portfolio Partners sold 1,232 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $10.6K.
ETF Portfolio Partners first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
ETF Portfolio Partners's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $10.6K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on ETF Portfolio Partners's 13F filing for Q2 2024, filed 15 Jul 2024.